Stockreport

4DMT to Participate in Upcoming Investor Conferences and Ophthalmology Innovation Summit XIV

4D Molecular Therapeutics, Inc.  (FDMT) 
PDF EMERYVILLE, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading clinical-stage genetic medicines company [Read more]